相关实验视频
Updated: Apr 6, 2026

07:27
Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
21.9K
在非典型帕金森症中嗅觉损失的当前前前景 - - 一篇评论文章
Katarzyna Bochniak1, Mateusz Soszyński1, Natalia Madetko-Alster2
1Department of Medicine, Faculty of Medicine, Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland.
Biomedicines
|October 26, 2024
概括
嗅觉丧失 (OL) 是非典型帕金森症 (APs) 的一个关键症状. 评估OL模式可以帮助区分AP并预测疾病进展,提供新的诊断和治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 嗅觉功能障碍 嗅觉功能障碍
背景情况:
- 非典型帕金森症 (APs) 包括运动,认知和自主症状.
- 嗅觉损失 (OL) 是一个重要的非运动症状,被低估,但对于AP差异诊断至关重要.
- 患有莱维体的痴呆症 (DLB) 显示明显的OL,而多系统性缩 (MSA) 通常是正常的; 渐进性上核麻 (PSP) 和皮层骨干退化 (CBD) 可能表现出轻微的OL.
研究的目的:
- 审查嗅觉损失 (程度和模式) 在非典型帕金森症 (APs) 发病和进展中的作用.
- 突出嗅觉测试作为潜在的非侵入性查工具来区分AP.
- 探索如何理解嗅觉缺陷可以告知有针对性的治疗策略.
主要方法:
- 关于异型帕金森症患者嗅觉丧失的文献综述.
- 分析嗅觉功能障碍与特定的AP亚型之间的关系.
- 讨论嗅觉测试的临床实用性.
主要成果:
- 嗅觉损失在不同的非典型帕金森症中存在显著差异.
- 明显的OL是DLB的特征,而轻微的OL可能存在于PSP和CBD中.
- MSA通常呈现出正常的嗅觉.
结论:
- 嗅觉测试可以作为一个有价值的,非侵入性的工具,用于APs的差异诊断.
- 标准化嗅觉测试协议是需要临床实施.
- 对APS嗅觉功能障碍的进一步研究可能会导致新的治疗方法.
相关概念视频
Neural Regulation
44.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.9K
Olfaction
49.9K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
49.9K
Olfactory Receptors: Location and Structure
14.5K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
14.5K
Physiology of Smell and Olfactory Pathway
14.2K
Humans detect odors with the help of specialized cells located in the upper part of the nasal cavity, called olfactory receptor neurons (ORNs). ORNs possess hair-like structures called cilia, which are receptive to sensations from the inhaled air. When an odorant molecule binds to a specific receptor on the cell of the cilia, it leads to a series of events that ultimately cause the ORN to send electrical signals to the olfactory bulb in the brain through the olfactory nerves.
The olfactory...
The olfactory...
14.2K
Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K

